SLDB
Price:
$5.92
Market Cap:
$461.22M
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new ...[Read more]
Industry
Biotechnology
IPO Date
2018-01-26
Stock Exchange
NASDAQ
Ticker
SLDB
According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 421.79M. This represents a change of 60.47% compared to the average of 262.85M of the last 4 quarters.
The mean historical Enterprise Value of Solid Biosciences Inc. over the last ten years is 284.17M. The current 421.79M Enterprise Value has changed 14.74% with respect to the historical average. Over the past ten years (40 quarters), SLDB's Enterprise Value was at its highest in in the September 2018 quarter at 1.47B. The Enterprise Value was at its lowest in in the December 2022 quarter at -83684020.00.
Average
284.17M
Median
177.18M
Minimum
-81042440.00
Maximum
806.30M
Discovering the peaks and valleys of Solid Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 121.21%
Maximum Annual Enterprise Value = 806.30M
Minimum Annual Increase = -216.15%
Minimum Annual Enterprise Value = -81042440.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 107.21M | 44.22% |
| 2023 | 74.34M | -191.73% |
| 2022 | -81042440.00 | -216.15% |
| 2021 | 69.77M | -71.41% |
| 2020 | 244.04M | 121.21% |
| 2019 | 110.32M | -86.32% |
| 2018 | 806.30M | 19.09% |
| 2017 | 677.08M | 58.45% |
| 2016 | 427.30M | 5.15% |
The current Enterprise Value of Solid Biosciences Inc. (SLDB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
33.50M
5-year avg
82.86M
10-year avg
284.17M
Solid Biosciences Inc.’s Enterprise Value is greater than Autolus Therapeutics plc (358.55M), greater than Quantum-Si incorporated (276.42M), greater than Rocket Pharmaceuticals, Inc. (319.22M), less than LB Pharmaceuticals Inc Common Stock (467.73M), greater than Aura Biosciences, Inc. (320.33M), greater than Benitec Biopharma Inc. (252.27M), less than Annexon, Inc. (432.32M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), less than Design Therapeutics, Inc. (540.75M), less than RAPT Therapeutics, Inc. (534.71M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 358.55M | $417.84M | |
| 276.42M | $287.46M | |
| 319.22M | $370.12M | |
| 467.73M | $487.01M | |
| 320.33M | $409.59M | |
| 252.27M | $345.94M | |
| 432.32M | $536.98M | |
| 251.41M | $379.96M | |
| 540.75M | $559.35M | |
| 534.71M | $570.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Solid Biosciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Solid Biosciences Inc. (SLDB)?
What is the 3-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?
What is the 5-year average Enterprise Value for Solid Biosciences Inc. (SLDB)?
How does the current Enterprise Value for Solid Biosciences Inc. (SLDB) compare to its historical average?